Taylor Yamauchi

University of Colorado Anschutz Medical Campus — United States

Medicine · Health Sciences

5h-index184citations18works5.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(16), Protein Degradation and Inhibitors(7), Epigenetics and DNA Methylation(5), Acute Lymphoblastic Leukemia research(5), Chronic Lymphocytic Leukemia Research(4)

Publications18 total

GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia
Blood·2025· 11 citedOpen Access
Aberrant Stemness Transcription Signature Unveils a Mechanism of Chemotherapy Resistance through Blunting p53-Mediated Response in Acute Myeloid Leukemia
Blood·2024
Supplemental Methods, Figures, and Tables from Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i>-Rearranged Leukemia
2023Open Access
Supplemental Table S6 from Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i>-Rearranged Leukemia
2023Open Access
Supplemental Table S4 from Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i>-Rearranged Leukemia
2023Open Access
Data from Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i>-Rearranged Leukemia
2023Open Access
Supplemental Table S4 from Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i>-Rearranged Leukemia
2023Open Access
Supplemental Table S6 from Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i>-Rearranged Leukemia
2023Open Access
Data from Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i>-Rearranged Leukemia
2023Open Access
Supplemental Methods, Figures, and Tables from Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i>-Rearranged Leukemia
2023Open Access
The Role of GATA2 in Drug Resistance in AML
Blood·2022
Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in <i>MLL</i> -Rearranged Leukemia
Molecular Cancer Therapeutics·2017· 62 cited
The Role of Gata2 in Murine Models of Acute Myeloid Leukemia
Blood·2016· 1 cited
Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia
Cell Reports·2016· 62 citedOpen Access
Inactivation of Eed impedes MLL-AF9–mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model
Experimental Hematology·2015· 23 cited
Epigenetic Modifiers in Normal and Malignant Hematopoiesis
Epigenomics·2015· 25 cited
Context Dependent Role of Polycomb Repressive Complex 2 in Acute Leukemia
Blood·2014
MDR1 Mediated Drug Resistance to a Histone Methyltansferase Inhibitor (KMT)
Blood·2014

Frequent Co-authors

Kathrin M. Bernt(17), Jessica N. Haladyna(14), Carly Campbell(9), David A. Drubin(9), Timothy M. Thomson(9), Michael J. Maria(9), Nigel J. Waters(9), Edward J. Olhava(9), Roy M. Pollock(9), J. Joshua Smith(9), Stephen J. Blakemore(9), Scott R. Daigle(9), Tobias Neff(9), Robert A. Copeland(8), Etienne Danis(7), Simone S. Riedel(7), Kristen Echanique(3), Nan Zhu(3), Huafeng Xie(3), Stuart H. Orkin(3)